BioCentury
ARTICLE | Clinical News

AERAS-404: Phase II started

March 24, 2014 7:00 AM UTC

Aeras began a partially blind South African Phase II trial to evaluate AERAS-404 in 990 adolescents who have previously been vaccinated with Bacille Calmette-Guerin (BCG) as infants. Subjects will rec...